Clinical Trial Update: MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of MDMA-assisted psychotherapy for posttraumatic stress disorder has completed and results were posted in late 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-10-25